LAPPE MARK (Chief Executive Officer) purchased 269.1% of their position (40K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $518.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/22/2024ACC: 0002007919-24-000038
DirectorOfficer· Chief Executive Officer
Since May 2024
+40K
Net shares
Net buyer
$518.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
40K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+27.05K
Price / share
$12.97
Trade value
$350.90K
% of position
182.0%
8/20/2024
14.87K→41.92K
Common Stock
Indirect
Shares
+12.95K
Price / share
$12.93
Trade value
$167.38K
% of position
30.9%
8/21/2024
41.92K→54.87K
Total
Net shares
+40K
Net value
$518.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/20/2024 | P · Purchase | +27.05K | $12.97 | $350.90K | 182.0% | 14.87K | 41.92K |
| Common Stock Indirect | 8/21/2024 | P · Purchase | +12.95K | $12.93 | $167.38K | 30.9% | 41.92K | 54.87K |
| Total | +40K | $518.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned125K
Common Stock
IndirectShares owned621.55K
Total
746.55K indirect746.55K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 125K | Indirect |
| Common Stock | 621.55K | Indirect |
| Total | 746.55K | 746.55K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported